Brazil researchers report more modest 50.4% efficacy for Sinovac vaccine | GMA News Online gmanetwork.com

1
admin 1 day ago in New Coronavirus Disease (COVID-19) 0

A coronavirus vaccine developed by China's Sinovac showed "general efficacy" of 50.38% in a late-stage trial in Brazil, the company's local partners said on Tuesday, revealing a more modest figure after pressure for more transparency.

voters
Report Story

Related Stories

  1. UK Covid-19 variant detected in PH | Inquirer
  2. PH authorizes Pfizer's COVID-19 vaccine for emergency use | CNN...
  3. COVID-19 pandemic: Latest situation in the Philippines – January 2021...
  4. Filipina nurse awarded British Empire Medal for ‘outstanding work’ during...
  5. Swab tests required for Manila residents returning from provinces |...
  6. PNP finds 'only 4 COVID-19 cases' recorded after Roque, Pacquiao...
  7. First Britons receive Covid-19 vaccine, a landmark moment in the...
  8. U.K. Approves Pfizer Coronavirus Vaccine, a First in the West...
  9. Galvez: COVID vaccination will start May 2021 barring unforeseen issues...
  10. Metro Manila, 4 provinces to ease into GCQ starting Aug....
Tags : Sinovac

Leave Your Comment

Leave a Reply

Pin It on Pinterest

Share This